Tenet Healthcare Corporation

Informe acción NYSE:THC

Capitalización de mercado: US$15.9b

Tenet Healthcare Crecimiento futuro

Future controles de criterios 0/6

Se prevé que los beneficios de Tenet Healthcare disminuyan en un 39.2% al año, mientras que se espera que sus ingresos anuales crezcan en un 3.5% al año. Se prevé que el BPA disminuya en un 41% por año. Se espera que la rentabilidad financiera sea de 11.4% en 3 años.

Información clave

-39.2%

Tasa de crecimiento de los beneficios

-41.0%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare20.9%
Tasa de crecimiento de los ingresos3.5%
Rentabilidad financiera futura11.4%
Cobertura de analistas

Good

Última actualización12 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services

Nov 04

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Oct 30
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare: Becoming A Very Healthy Business

Sep 09

Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Sep 06
Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)

Aug 29

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Aug 13
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Jul 11
An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Jun 17

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

May 21
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Apr 30
Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Mar 18
Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Tenet Healthcare: Shrinking To Grow

Feb 04

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Dec 18
Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Nov 15
We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Oct 13

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Aug 02
Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Jul 28

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

Apr 13
Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

USPI and Providence extend hands to aid ambulatory surgical services

Feb 09

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Jan 31
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Previsiones de crecimiento de beneficios e ingresos

NYSE:THC - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/202622,4711,1782,1322,75015
12/31/202521,4321,0692,1042,47317
12/31/202420,7943,1501,9802,43417
9/30/202420,9723,1262,3933,202N/A
6/30/202420,9162,7551,8912,660N/A
3/31/202420,8952,6191,7552,511N/A
12/31/202320,5486111,6232,374N/A
9/30/202320,1594691,1381,971N/A
6/30/202319,8944999611,783N/A
3/31/202319,4534144621,304N/A
12/31/202219,1744103211,083N/A
9/30/202219,0405582431,019N/A
6/30/202219,1338754141,136N/A
3/31/202219,4499575701,262N/A
12/31/202119,4859159101,568N/A
9/30/202119,5441,0791,1371,657N/A
6/30/202119,2074341,3231,818N/A
3/31/202117,9014023,3333,812N/A
12/31/202017,6403992,8673,407N/A
9/30/202017,531-182,9293,481N/A
6/30/202017,542-482,6853,307N/A
3/31/202018,454-1126921,352N/A
12/31/201918,479-2265631,233N/A
9/30/201918,292-228258963N/A
6/30/201918,213-10197882N/A
3/31/201918,159-10280946N/A
12/31/201818,3131014321,049N/A
9/30/201818,672-1176711,290N/A
6/30/201818,769-474N/A1,260N/A
3/31/201819,065-554N/A1,127N/A
12/31/201719,179-704N/A1,200N/A
9/30/201719,061-553N/A416N/A
6/30/201719,324-196N/A377N/A
3/31/201719,390-184N/A597N/A
12/31/201619,621-187N/A558N/A
9/30/201619,787-208N/A1,042N/A
6/30/201619,630-227N/A1,255N/A
3/31/201619,254-243N/A1,230N/A
12/31/201518,634-142N/A1,026N/A
9/30/201518,07319N/A1,054N/A
6/30/201517,55657N/A793N/A
3/31/201517,101107N/A649N/A
12/31/201416,60334N/A687N/A
9/30/201416,023-44N/A723N/A
6/30/201414,256-21N/A708N/A
3/31/201412,641-64N/A602N/A
12/31/201311,087-123N/A589N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que los beneficios de THC disminuyan en los próximos 3 años (-39.2% al año).

Beneficios vs. Mercado: Se prevé que los beneficios de THC disminuyan en los próximos 3 años (-39.2% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de THC disminuyan en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.5% al año) de THC crezcan más despacio que el mercado de US (8.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.5% al año) de THC crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de THC sea baja dentro de 3 años (11.4%).


Descubre empresas en crecimiento